Insider · CIK 0002048593
Sean Saint
Files at BBNX (Beta Bionics, Inc.). First filing Jun 4, 2025, latest Sep 4, 2026.
In brief
Sean Saint files SEC Form 4 as CEO, president and director at BBNX (Beta Bionics, Inc.). Since Jun 4, 2025, Sean Saint has reported 0 open-market buys worth $0 and 7 open-market sells worth $911k, the latest filed on Sep 4, 2026.
A track record needs three past buys with six months of prices behind them; Sean Saint has 0, so none is measured yet.
The newest scored trade: sold $113k of BBNX on Sep 3, 2026, filed Sep 4, 2026, scored 30 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 5 sells worth $786k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BBNX: Beta Bionics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Beta Bionics, Inc. | $113k 5,641 shares | -1% | +125% from low-38% from high | |
| 54Moderate | Beta Bionics, Inc. | $322k 16,867 shares | -4% | +119% from low-39% from high | |
| 52Moderate | Beta Bionics, Inc. | $213k 16,872 shares | -4% | +44% from low-60% from high | |
| 46Moderate | Beta Bionics, Inc. | $42k 3,384 shares | -1% | +29% from low-61% from high | |
| 50Moderate | Beta Bionics, Inc. | $96k 3,278 shares | -3% | +193% from low-10% from high | |
| 48Moderate | Beta Bionics, Inc. | $63k 3,359 shares | -3% | +96% from low-20% from high | |
| 47Moderate | Beta Bionics, Inc. | $62k 3,439 shares | -3% | +92% from low-22% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 3, 2026 | BBNX Beta Bionics Inc | 5,641 0.01% of outstanding | $113k | Sep 3, 2026 | none |
| Sep 3, 2026 | BBNX BETA BIONICS, INC. | 16,867 0.04% of outstanding | $327k | Sep 2, 2026 | $213k |
| Jun 3, 2026 | BBNX BETA BIONICS, INC. | 16,872 0.04% of outstanding | $216k | Jun 2, 2026 | $42k |
| Mar 4, 2026 | BBNX BETA BIONICS, INC. | 3,384 0.01% of outstanding | $42k | Mar 2, 2026 | $96k |
| Dec 4, 2025 | BBNX BETA BIONICS, INC. | 3,278 0.01% of outstanding | $96k | Dec 2, 2025 | $63k |
| Jun 9, 2025 | BBNX BETA BIONICS, INC. | 3,439 0.01% of outstanding | $62k | Jun 2, 2025 | none |
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,641 | $20.08 | $113k | 398,429 | 40 d ago |
| Sep 2, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -16,867 | $19.11 | $322k | 404,070 | 41 d ago |
| Jun 2, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -16,872 | $12.61 | $213k | 420,937 | Jun 3, 2026 |
| Feb 27, 2026 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +287,944 | $0.00 | $0 | 287,944 | Mar 13, 2026 |
| Feb 27, 2026 | BBNX Beta Bionics, Inc. | AGrant or award Common Stock | +343,269 | $0.00 | $0 | 441,193 | Mar 3, 2026 |
| Mar 2, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -3,384 | $12.36 | $42k | 437,809 | Mar 3, 2026 |
| Feb 27, 2026 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +184,837 | $0.00 | $0 | 184,837 | Mar 3, 2026 |
| Dec 2, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -3,278 | $29.34 | $96k | 97,924 | Dec 4, 2025 |
| Sep 2, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -3,359 | $18.86 | $63k | 101,202 | Sep 4, 2025 |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -943 | $17.03 | $16k | 107,057 | Jun 4, 2025 |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -2,185 | $18.15 | $40k | 104,872 | Jun 4, 2025 |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -311 | $18.69 | $5,813 | 104,561 | Jun 4, 2025 |
| Feb 27, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Common Stock | +108,000 | $0.00 | $0 | 108,000 | Mar 3, 2025 |
| Feb 27, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +163,000 | $0.00 | $0 | 163,000 | Mar 3, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +749,445 | $0.00 | $0 | 749,445 | Feb 3, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +83,268 | $0.00 | $0 | 83,268 | Feb 3, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +494,198 | $0.00 | $0 | 494,198 | Feb 3, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +54,911 | $0.00 | $0 | 54,911 | Feb 3, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +467,944 | $0.00 | $0 | 467,944 | Feb 3, 2025 |
| Jan 29, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +467,944 | $0.00 | $0 | 467,944 | Jan 31, 2025 |
Questions about Sean Saint
Answered from the filings on this page, as of the latest one.
Is Sean Saint buying or selling?
In the last 12 months Sean Saint reported 0 open-market buys worth $0 and 5 open-market sells worth $786k on SEC Form 4; the latest was sold $113k of BBNX on Sep 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Sean Saint's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sean Saint has 0.
Where does Sean Saint file Form 4?
Sean Saint has filed Form 4 at BBNX (Beta Bionics, Inc.) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.